PDCD1 and triple-negative breast carcinoma: One study from Europe found that PD-1 positive immune cells correlated with longer disease free survival time in triple negative breast cancer (TNBC), and the density of TILs was notably associated with PD-1 and PD-L1 expression in immune cells (21).